期刊文献+
共找到875篇文章
< 1 2 44 >
每页显示 20 50 100
Efficacy and safety of Xiangsha Liujunzi granules for functional dyspepsia: A multi-center randomized double-blind placebo-controlled clinical study 被引量:40
1
作者 Lin Lv Feng-Yun Wang +9 位作者 Xiang-Xue Ma Zhen-Hua Li Sui-Ping Huang Zhao-Hong Shi Hai-Jie Ji Li-Qun Bian Bei-Hua Zhang Ting Chen Xiao-Lan Yin Xu-Dong Tang 《World Journal of Gastroenterology》 SCIE CAS 2017年第30期5589-5601,共13页
AIM To assess the efficacy and safety of a Chinese herbal medicine (CHM), Xiangsha Liujunzi granules, in the treatment of patients with functional dyspepsia (FD). METHODS We performed a randomized, double-blind, place... AIM To assess the efficacy and safety of a Chinese herbal medicine (CHM), Xiangsha Liujunzi granules, in the treatment of patients with functional dyspepsia (FD). METHODS We performed a randomized, double-blind, placebo-controlled trial with patients from three centers. Two hundred and sixteen subjects diagnosed with FD according to ROME. criteria and confirmed by upper gastrointestinal endoscopy and spleen-deficiency and Qi-stagnation syndrome were selected to receive Xiangsha Liujunzi granules or placebo for 4 wk in a 2: 1 ratio by blocked randomization. The subjects also received follow-up after the 4-wk intervention. Herbal or placebo granules were dissolved in 300 mL of water. Participants in both groups were administered 130 mL (45 degrees C) three times a day. Participants were evaluated prior to and following 4 wk of the intervention in terms of changes in the postprandial discomfort severity scale (PDSS) score, clinical global impression (CGI) scale score, hospital anxiety and depression scale (HADS) score, traditional Chinese medicine symptoms score (SS), scores of various domains of the 36-item short form health survey (SF-36), gastric emptying (GE) and any observed adverse effects. RESULTS Compared with the placebo group, patients in the CHM group showed significant improvements in the scores of PDSS, HADS, SS, SF-36 and CGI scale (P < 0.05 or P < 0.01). They also showed the amelioration in the GE rates of the proximal stomach and distal stomach (P < 0.05 or P < 0.01). CONCLUSION Xiangsha Liujunzi granules offered significant symptomatic improvement in patients with FD. 展开更多
关键词 Functional dyspepsia Chinese herbal medicine Xiangsha liujunzi Efficacy Randomized controlled trial
暂未订购
Effects of Xiangsha Liujunzi decoction drug serum on gastric antrum smooth muscle cells from rats with functional dyspepsia by regulating gastrointestinal hormones 被引量:6
2
作者 Ning Dai Jinghong Hu +7 位作者 Yan Liu Dongyu Ge Ruijuan Dong Fengzhi Wu Jiaojiao Yu Mindan Chen Deborah CMa Feng Li 《Journal of Traditional Chinese Medical Sciences》 2020年第1期45-52,共8页
Objective:To observe the effect and mechanism of Xiangsha Liujunzi decoction(XSLJZD)drug serum on gastric antrum smooth muscle cells(SMCs)in rats with functional dyspepsia(FD).Methods:Gastric antrum SMCs from rats wit... Objective:To observe the effect and mechanism of Xiangsha Liujunzi decoction(XSLJZD)drug serum on gastric antrum smooth muscle cells(SMCs)in rats with functional dyspepsia(FD).Methods:Gastric antrum SMCs from rats with FD were isolated,cultured,and then divided into six groups as follows:control,model,domperidone,low-dose XSLJZD(LXSLJZD),medium-dose XSLJZD(MXSLJZD),and high-dose XSLJZD(HXSLJZD).Each group was administered the corresponding drug serum for intervention.Drug serum intervention conditions and proliferative activity of SMCs were tested by cholecystokinin octapeptide.Ghrelin,gastrin,somatostatin,and substance P(SP)levels were measured by ELISA.Somatostatin and SP mRNA expression was measured by real-time PCR.Results:A concentration of 10%drug serum for 24 h was decided to be the best intervention condition for later study.The mean optical density value in the model group was lower than that in the control group(P紏.001).Optical density values in the domperidone and HXSLJZD groups were higher than those in the model group(P?.025,P?.032,respectively).Gastrin,SP,and ghrelin levels in the model group were lower(P?.007,P?.037,P?.005,respectively),but somatostatin levels were higher,compared with those in the control group(P?.031).Gastrin,SP,and ghrelin levels in the domperidone,MXSLJZD,and HXSLJZD groups were higher than those in the model group(all P<.05).Somatostatin levels in the four drug-treated groups were lower than those in the model group(P?.002,P?.007,P?.001,P?.009,respectively).SP mRNA levels in the model group were lower than those in the control,domperidone,MXSLJZD,and HXSLJZD groups(P?.037 P?.016,P?.025,P?.002,respectively).Somatostatin mRNA levels in the model group were higher than those in the control and MXSLJZD groups(P紏.042,P紏.035).Conclusions:XSLJZD and domperidone drug serum effectively promote proliferative activity of gastric antrum SMCs in an FD model.The mechanism of this activity may be regulated by gastrointestinal hormones. 展开更多
关键词 Functional dyspepsia Xiangsha liujunzi decoction Gastrointestinal hormones Gastric antrum Smooth muscle cells
暂未订购
Mechanism underlying the effect of Liujunzi decoction(六君子汤)on advanced-stage non-small cell lung cancer in patients after first-line chemotherapy 被引量:2
3
作者 XIN Xiaoli WANG Guodong +4 位作者 HAN Ru JIANG Yi LIU Chang LIU Lingshuang XU Zhenye 《Journal of Traditional Chinese Medicine》 SCIE CSCD 2022年第1期108-115,共8页
OBJECTIVE:To further clarify the anticancer mechanisms of Liujunzi decoction(六君子汤)and provide possible targets for the treatment of advanced-stage nonsmall cell lung cancer(NSCLC)by re-analyzing differential gene ... OBJECTIVE:To further clarify the anticancer mechanisms of Liujunzi decoction(六君子汤)and provide possible targets for the treatment of advanced-stage nonsmall cell lung cancer(NSCLC)by re-analyzing differential gene expression profile of peripheral blood mononuclear cells(PBMCs)from Liujunzi decoctiontreated NSCLC patients receiving first-line chemotherapy.METHODS:The PBMC gene expression microarray data set GSE61926 was retrieved from a high throughput gene expression database.Differentially expressed genes(DEGs)were screened by paired sample t-test and the multiple ratio method.Gene ontology and Kyoto encyclopedia of genes and genomes(KEGG)pathway analyses were performed using the DAVID database.The protein–protein interaction(PPI)network was constructed using interaction gene library retrieval tools and Cytoscape software.RESULTS:A total of 162 DEGs were identified,with 67 upregulated genes and 95 downregulated genes.The functional distribution of Gene Oncology(GO)genes showed that DEGs were mostly concentrated in extracellular regions,calcium ion binding,and transcriptase activity.KEGG pathway analysis showed that cytokine–cytokine receptor interactions were significantly enriched.PPI network analysis screened out the top 10 central protein-coding genes with the highest nodal degree:IL2,PIWIL4,DICER1,PIWIL2,SAA1,XCL1,IL22RA1,ARHGAP11A,DCP1A,and GDNF.Among them,the central protein-coding gene with the highest node degree was IL2.In addition,the central protein-coding genes with high node degrees and high molecular complex detection(MCODE)scores were PIWIL4,DICER1,PIWIL2,and DCP1A,all of which are related to tumor development.CONCLUSIONS:One signaling pathway and 10 central protein-coding genes related to anticancer mechanisms were screened by re-analysis of GSE61926 data.IL2,PIWIL4,DICER1,PIWIL2,and DCP1 A may have important roles in the mechanism of Liujunzi decoction treatment against NSCLC.Our results suggest that the anticancer mechanism of Liujunzi decoction may be related to gene silencing by RNA and the biological processes of piwi-interacting RNA and other small RNAs. 展开更多
关键词 CARCINOMA non-small-cell lung antineoplastic agents computational biology RNA small interfering liujunzi decoction
原文传递
Liujunzi decoction ameliorats cisplatin-induced anorexia via adjusting metabolic disorders in rats
4
作者 DAI Yong-zhao CHEN Si-qi NIE Ke 《中国药理学与毒理学杂志》 CAS 北大核心 2021年第10期728-729,共2页
OBJECTIVE Cisplatin is a formidable chemotherapy agent widely applying in antineoplastic treatments,but its side effects often limit the clinical usage.Metabolic disorders are one of the side effects induced by cispla... OBJECTIVE Cisplatin is a formidable chemotherapy agent widely applying in antineoplastic treatments,but its side effects often limit the clinical usage.Metabolic disorders are one of the side effects induced by cisplatin,which closely relate to the onset of chemotherapy-induced anorexia(CIA)in cancer patients but lacks effective controls.Liujunzi decoction(LJZD)is a traditional Chinese formula that has a promising effect in treating CIA.However,whether LJZD ameliorates CIA through adjusting cisplatin-induced metabolic disorders remain unknow.The present study evaluated the mechanism of cisplatin-induced metabolic disorders,and the effect of LJZD in ameliorating these disturbances.METHODS 42 male Sprague-Dawley(SD)rats(180-220 g)were randomly divided into 3 groups:normal control group(distilled water+saline),model group(distilled water+cisplatin),LJZD group(4.8 g·kg^(-1)Liujunzi decoction ingredients+cisplatin).Intragastrical administered each drug twice a day(7∶00-19∶00)since day 0 for 4 d,animals were intraperitoneal injected with cisplatin 6 mg·kg^(-1)1 h after administration while normal control groups were injected with same volume of saline.On day 3,each group was anesthetized with pentobarbital sodium 45 mg·kg^(-1)(ip),and blood samples were collected from aorta abdominalis.Then the samples were analyzed using an LC-ESI-MS/MS system.Significantly regulated metabolites between groups were determined by VIP≥1 and absolute Log2FC(fold change)≥1.Identified metabolites were mapped to Kyoto Encyclopedia of Genes and Genomes(KEGG)pathway database using Metaboanalyst 5.0(https://www.metaboanalyst.ca/).RESULTS A total of 133,77 and 32 differential metabolites were filtrated in control vs model,control vs LJZD and model vs LJZD groups respectively.Comparing to control,the levels of hexadecanoic acid(Log2FC=6.3153),linoleic acid(Log2FC=5.3478),and 8,11-icosadienoic acid(Log2FC=5.2342)significantly increased,and the levels of N-acetyl-L-tyrosine(Log2FC=-2.6283),cinnamic acid(Log2FC=-2.3381),N-acetylphenylalanine(Log2FC=-2.2501)significantly decreased in model group.The KEGG pathway enrichments of these metabolites indicated that,cisplatin-induced metabolic disorders by disturbing metabolism pathways such as linoleic acid metabolism,biosynthesis of unsaturated fatty acids,and phenylalanine metabolism,which suggested that the onset of CIA was partly associated with the metabolic disorders of linoleic acid,unsaturated fatty acids,and phenylalanine.Compared to control,treatment of LJZD significantly increased the levels of 4-hydroxytryptamine(Log2FC=12.0186),hexadecanoic acid(Log2FC=5.7412),linoleic acid(Log2FC=5.1877)and significantly decreased the levels of N-acetylmethionine(Log2FC=-1.7317),2-aminoethanesulfinic acid(Log2FC=-1.6578),N-acetyl-L-tyrosine(Log2FC=-1.5355).And comparing to the model group,4-hydroxytryptamine(Log2FC=12.0186),7,12-diketocholic acid(Log2FC=2.0998),N-acetylneuraminic acid(Log2FC=2.0560)markedly increased,and 3-hydroxy-3-methylpentane-1(Log2FC=-1.9202),5-dioic acid(Log2FC=-1.7166),N-isovaleroylglycine,hexanoyl glycine(Log2FC=-1.4958)markedly decreased in LJZD group.It was worth noting that,there were 23 differential metabolites filtrated both in control vs model and model vs LJZD groups,which were the key metabolites of LJZD in treating CIA.Among these 23 common metabolites,there were 16 metabolites excluding the control vs LJZD group,that was,LJZD had no effect in normal rats while being able to ameliorated cisplatin-induced metabolic disorders by regulating these 16 metabolites.Cisplatin-induced downregulation of 11 metabolites such as hydrocinnamic acid,(±)12(13)epoxy-9Z-octadecenoic acid,cinnamic acid were upregulated after LJZD treatment,and cisplatin-induced upregulation of imidazoleacetic acid,2′-deoxycytidine-5′-monophosphate and other 5 metabolites were downregulated by LJZD.The KEGG pathway analysis indicated that the linoleic acid metabolism,histidine metabolism,and pyrimidine metabolism were the most enriched metabolic pathway.Thus,cisplatin-induced metabolic disturbances mainly by disturbing linoleic acid metabolism,histidine metabolism,and pyrimidine metabolism,and LJZD interacted with these metabolic pathways to reduce metabolic disorders and thus ameliorated CIA.CONCLUSION Cisplatin-induced anorexia was closely related to the metabolic disorders of linoleic acid metabolism,biosynthesis of unsaturated fatty acids,and phenylalanine metabolism.The mechanism of LJZD in ameliorating CIA was in concerned with the metabolic adjustments,relating to the regulation of linoleic acid metabolism,histidine metabolism,and pyrimidine metabolism. 展开更多
关键词 liujunzi decoction chemotherapy-induced anorexia CISPLATIN METABOLOMIC metabolic disorders
暂未订购
Clinical Effect of Chemotherapy Combined with Chaishao Liujunzi Decoction in the Treatment of Breast Cancer
5
作者 ZHU Zumei 《外文科技期刊数据库(文摘版)医药卫生》 2021年第10期1086-1090,共8页
Objective: to study the therapeutic effect of chemotherapy combined with Chaishao Liujunzi decoction on breast cancer. Methods: 130 cases of breast cancer patients admitted to our hospital from September 2020 to Septe... Objective: to study the therapeutic effect of chemotherapy combined with Chaishao Liujunzi decoction on breast cancer. Methods: 130 cases of breast cancer patients admitted to our hospital from September 2020 to September 2021 were randomly divided into control group and experimental group according to the computer method. There were 65 cases in each group, and the patients in the control group received routine chemotherapy and medication. The patients in the experimental group were treated with Chaishao Liujunzi Decoction on the basis of the control group. The curative effect, TCM symptom score before and after the intervention and myelosuppression status (platelet count, white blood cell count and hemoglobin concentration) of the two groups were compared. Results: compared with the effective rate of comprehensive treatment, 64 cases (98.46%) in the experimental group and 58 cases (89.23%) in the control group were comprehensively effective (P < 0.05). Before treatment, there was no significant difference between the two groups (P>0.05). After treatment, the TCM waiting score of the experimental group was better than that of the control group (P<0.05). Before treatment, there was no significant difference in platelet count, leukocyte count and hemoglobin concentration between the two groups (P > 0.05). After treatment, the measurement results of various myelosuppression indexes in the experimental group were significantly better than those in the control group (P < 0.05). The incidence of adverse reactions in the experimental group on the 2nd day of chemotherapy was significantly lower than that in the control group (p < 0.05). Conclusion: the application of Chaishao Liujunzi Decoction in the clinical treatment of breast cancer patients undergoing chemotherapy can improve the patient's symptoms, and the curative effect is ideal. It is recommended to be popularized. 展开更多
关键词 CHEMOTHERAPY chaishao liujunzi decoction breast cancer clinical efficacy
暂未订购
Liujunzi Decoction Regulated Intestinal Flora Homeostasis to Relieve Lung–Gut Axis Inflammation in Asthma Flora Disorder Mice:Possibly Related to GATA3/ILC2
6
作者 XU Wen-ting WANG Qi +2 位作者 WU Xin-yu HUANG Jing-han WANG Jing 《Chinese Journal of Integrative Medicine》 2025年第11期1001-1010,共10页
Objective:To explore the effects and mechanism of Chinese medicine Liujunzi Decoction(LJZD)on regulating microbial flora in mice with asthma flora disorder.Methods:Thirty BALB/c female mice were divided into control,m... Objective:To explore the effects and mechanism of Chinese medicine Liujunzi Decoction(LJZD)on regulating microbial flora in mice with asthma flora disorder.Methods:Thirty BALB/c female mice were divided into control,model,LJZD[3.5 g/(kg·d),by gavage],dexamethasone[DXMS,0.7 mg/(kg·d),intraperitoneal injection],and Clostridium butyricum[CB,230 mg/(kg·d),by gavage]groups according to a random number table,6 mice in each group.The asthma flora disorder mice model was induced with ovalbumin(OVA).Lung and gut lesions were analyzed by hematoxylin-eosin(HE)and periodic acid-Schiff(PAS)stainings.The secretory immunoglobulin A(slgA)protein expression in lung and gut tissues was detected by Western blot.Flow cytometry was used to detect the relative counts of GATA binding protein 3(GATA3)/type 2 innate lymphoid cells(ILC2)in lung and gut.The levels of inflammatory factors in lung and gut tissues were detected by enzyme-linked immunosorbent assay(ELISA).Chao1 and Shannon index were used to compare microbial abundance and diversity in alveolar lavage fluid and cecal contents.The similarity or difference in the composition of mice microbial communities was analyzed through cluster analysis.The serum short-chain fatty acids(SCFAs)content was detected by ultra performance liquid chromatograph mass spectrometer(LC-MS)/MS.Results:The asthma flora disorder model mice showed obvious asthma-related symptoms,but LJZD treatment effectively alleviated these symptoms.LJZD restored alveolar wall thickening,airway inflammatory cell infiltration,gut tissue structure destruction,and inflammatory cell infiltration in asthma flora disorder mice.LJZD downregulated the slgA protein expression in mice(P<0.05).Moreover,LJZD decreased the activation of GATA3/ILC2s in lung and gut tissue(P<0.01),and reduced the levels of interleukin(IL)-5,IL-33,IL-25,IL-9 and IL-13(P<0.01).LJZD treatment returned the abundance of microbial species and the microbial community structure of alveolar lavage fluid and cecal content in asthma flora disorder mice to the normal state.The SCFAs content and body metabolism were also improved.Conclusion:LJZD exerted anti-asthmatic effects by improving the microbial balance of lung-gut axis and affecting systemic metabolism,consequently regulating the GATA3/ILC2s axis to impact the lung inflammatory response. 展开更多
关键词 liujunzi Decoction lung-gut axis microbial diversity GATA binding protein 3/type 2 innate lymphoid cells asthma flora disorder Chinese medicine
原文传递
加味香砂六君子汤调控高脂血症小鼠肠源性HDL3改善肝脏炎症反应的机制研究
7
作者 车梦竹 张琦 +3 位作者 隋国媛 闵冬雨 贾连群 杨关林 《中国中药杂志》 北大核心 2026年第1期232-240,共9页
探讨加味香砂六君子汤调控肠道高密度脂蛋白3(high-density lipoprotein 3,HDL3)水平改善高脂血症小鼠肝脏炎症的作用机制。将肠特异性ATP结合盒转运体A1(ATP-binding cassette transporter A1,ABCA1)基因敲除小鼠(Abcal-Villin-cre-Tg... 探讨加味香砂六君子汤调控肠道高密度脂蛋白3(high-density lipoprotein 3,HDL3)水平改善高脂血症小鼠肝脏炎症的作用机制。将肠特异性ATP结合盒转运体A1(ATP-binding cassette transporter A1,ABCA1)基因敲除小鼠(Abcal-Villin-cre-Tg)随机分为3组,每组8只:肠特异性敲除组(Abcal^(△Vill)组),肠特异性敲除高脂组(Abcal^(△Vill)+HFD组),肠特异性敲除中药干预组(Abcal^(△Vill)+HFD+M-XS组);同窝对照小鼠随机分为3组,每组8只:空白组(Abcal^(fl/fl)组),高脂组(Abcal^(fl/fl)+HFD组),中药干预组(Abcal^(fl/fl)+HFD+M-XS组)。除Abcal^(fl/fl)组和Abcal^(△Vill)组外,其余组给予高脂饲料饲养10周。连续给药6周,给药剂量23.66 g·kg^(-1)·d^(-1)。检测各组小鼠血脂四项;肝脏HE、油红O染色及回肠HE染色观察病理情况;酶联免疫吸附测定法(ELISA)检测小鼠回肠HDL3水平;GPO-PAP法检测肝脏甘油三酯(triacylglycerol, TG)水平;免疫荧光检测肝脏组织CD86与Toll样受体4(Toll-like receptor 4,TLR4)共定位情况;real-time PCR检测肝脏脂多糖结合蛋白(lipopolysaccharide-binding protein, LBP)、核转录因子-κB p65(nuclear factor kappa-light-chain-enhancer of activated B cells p65,NF-κB p65)、核因子-κBα抑制蛋白(inhibitor of nuclear factor kappa-B alpha, IκBα)、白细胞介素6(interleukin-6,IL-6)、肿瘤坏死因子-α(tumor necrosis factor alpha, TNF-α)、白细胞介素-1β(interleukin-1 beta, IL-1β)mRNA表达;Western blot检测回肠ABCA1、载脂蛋白A-I(apolipoprotein A-I,apoA-I)及肝脏LBP、p-NF-κB、p-IκBα、IL-6、TNF-α和IL-1β蛋白表达。结果显示,与Abcal^(fl/fl)组比,Abcal^(fl/fl)+HFD组血脂水平升高,肝脏出现大量空泡及脂滴,小肠绒毛变短,肝脏TG升高,回肠HDL3、ABCA1和apoA-I水平降低,肝脏CD86与TLR4呈现共定位,肝脏LBP、NF-κB、IκBα、IL-6、TNF-α及IL-1β mRNA表达升高,肝脏LBP、p-NF-κB、p-IκBα、IL-6、TNF-α及IL-1β蛋白表达显著升高(P<0.05);与Abcal^(fl/fl)+HFD组比,Abcal^(fl/fl)+HFD+M-XS组血脂水平降低,肝脏空泡及脂滴减少,小肠绒毛长度增加,肝脏TG降低,回肠HDL3、ABCA1和apoA-I水平升高,肝脏CD86与TLR4共定位程度减弱,LBP、NF-κB、IκBα、IL-6、TNF-α及IL-1β mRNA表达降低,LBP、p-NF-κB、p-IκBα、IL-6、TNF-α及IL-1β蛋白表达显著降低(P<0.05);与Abcal^(fl/fl)+HFD组比,Abcal^(△Vill)+HFD组血脂水平升高,肝脏空泡及脂滴增多,肝脏TG升高,肝脏CD86与TLR4共定位程度增强,LBP、NF-κB、IκBα、IL-6、TNF-α及IL-1β mRNA表达升高,LBP、p-NF-κB、p-IκBα、TNF-α及IL-1β蛋白表达显著升高(P<0.05);与Abcal^(fl/fl)+HFD+M-XS组比,Abcal^(△Vill)+HFD+M-XS组血脂水平升高,肝脏空泡及脂滴增多,肝脏TG升高,肝脏CD86与TLR4共定位增强,LBP、NF-κB、IκBα、IL-6、TNF-α及IL-1β mRNA表达升高,LBP、p-NF-κB、p-IκBα、IL-6、TNF-α及IL-1β蛋白表达显著升高(P<0.05)。结果表明,加味香砂六君子汤通过调节肠道HDL3水平,改善肝脏炎症反应,纠正血脂异常。 展开更多
关键词 加味香砂六君子汤 小鼠 回肠 高密度脂蛋白3 血脂
原文传递
基于UHPLC-Q/TOF-MS非靶向代谢组学分析六君子汤调节脾虚泄泻的作用机制
8
作者 钱景锐 廖志涵 +5 位作者 姜奇瑶 韩杉 喻良文 莫友胜 王奇 卓越 《中国药理学通报》 北大核心 2026年第1期172-180,共9页
目的从代谢水平解析经典名方六君子汤(Liujunzi decoction,LJZD)改善小鼠脾虚泄泻的潜在效应机制。方法将56只昆明小鼠分为空白组和模型组,采用番泻叶水煎液灌胃结合饮食失节法,建立脾虚泄泻小鼠模型。造模结束后将小鼠分为模型组、LJZ... 目的从代谢水平解析经典名方六君子汤(Liujunzi decoction,LJZD)改善小鼠脾虚泄泻的潜在效应机制。方法将56只昆明小鼠分为空白组和模型组,采用番泻叶水煎液灌胃结合饮食失节法,建立脾虚泄泻小鼠模型。造模结束后将小鼠分为模型组、LJZD低、中、高剂量组。LJZD低、中、高剂量组分别给予LJZD(10、20、30 g·kg^(-1)·d^(-1))灌胃,空白组及模型组给与等体积的生理盐水。记录体质量变化,比色法测定D-木糖含量、α-淀粉酶活性,WST-1法测定总超氧化物歧化酶,HE染色观察结肠黏膜组织形态,非靶向代谢组学筛选小鼠血清差异代谢物,结合网络药理学方法分析LJZD的潜在作用靶点和机制。结果与空白组相比,模型组体质量下降明显(P<0.01),D-木糖含量、α-淀粉酶活性、总超氧化物歧化酶活力明显下降(P<0.05,P<0.01),结肠黏膜组织损伤明显;与模型组相比,LJZD低、中剂量组体质量升高(P<0.05,P<0.01),D-木糖含量、α-淀粉酶活性、总超氧化物歧化酶活力明显升高(P<0.05,P<0.01),结肠上皮细胞和黏膜组织损伤明显改善。代谢组学PCA与OPLS-DA结果显示,LJZD组与模型组之间有差异,通过对照3组的交集,共找到13个LJZD治疗脾虚泄泻的生物标志物,联合分析共获得314个LJZD的潜在靶点,网络拓扑分析发现STAT3、MAPK1、EGFR、ESR1、MAPK3、JAK2、PIK3CA、IL-6等可能是LJZD的关键靶点,主要涉及PI3K/Akt信号通路、MAPK信号通路等。结论本研究揭示了LJZD可回调脾虚泄泻小鼠异常代谢轮廓发挥止泻作用,其效应机制可能与调控炎症及屏障修复等相关途径有关。 展开更多
关键词 六君子汤 脾虚泄泻 代谢组学 差异代谢物 PI3K/AKT信号通路 MAPK信号通路
暂未订购
“扶正调气”理论指导下运用香砂六君子汤治疗肺癌
9
作者 张迪 张兴 +1 位作者 郑红刚 花宝金 《天津中医药大学学报》 2026年第3期257-261,共5页
“扶正调气”的理论内涵包括调补肺脾肾之气,调理脾胃升降,并配合疏肝安神以畅情志,达到扶正气,调气机,从而促进气血恢复,痰、瘀、毒等病理产物消散的目的。肺癌的发病率及病死率在中国恶性肿瘤中均居第一位,且一直呈现增长趋势。正虚... “扶正调气”的理论内涵包括调补肺脾肾之气,调理脾胃升降,并配合疏肝安神以畅情志,达到扶正气,调气机,从而促进气血恢复,痰、瘀、毒等病理产物消散的目的。肺癌的发病率及病死率在中国恶性肿瘤中均居第一位,且一直呈现增长趋势。正虚是肺癌形成的基本病机,气机升降失衡是肺癌发生发展的关键因素。中医治疗肺癌可以通过“扶正调气”的方法,扶助正气,调理升降。香砂六君子汤是临床常用方剂,调和脾胃,理气化痰,以达补泻合用,升降相因之效,切合“扶正调气”的思想。临床中基于“扶正调气”理论运用香砂六君子汤化裁治疗肺癌,往往收效满意。 展开更多
关键词 香砂六君子汤 扶正调气 肺癌 脾胃 升降
暂未订购
董幼祺运用二陈汤及类方治疗小儿痰湿证验案举隅
10
作者 常婉莹 董幼祺 《中国中西医结合儿科学》 2026年第1期67-70,共4页
二陈汤为治疗痰湿证之基础方,历代医家推崇为“治痰之总剂”。小儿素体虚弱,易因脾失健运而生湿酿痰,痰湿内阻可致呼吸、消化及情志等多系统疾病。董幼祺教授基于小儿“脾常不足”“肺常不足”的生理特点,结合“脾为生痰之源,肺为贮痰... 二陈汤为治疗痰湿证之基础方,历代医家推崇为“治痰之总剂”。小儿素体虚弱,易因脾失健运而生湿酿痰,痰湿内阻可致呼吸、消化及情志等多系统疾病。董幼祺教授基于小儿“脾常不足”“肺常不足”的生理特点,结合“脾为生痰之源,肺为贮痰之器”的病机理论,秉承“治痰先理气、健脾以绝痰源”之法,灵活运用二陈汤及类方温胆汤、六君子汤等,随证加减,标本兼顾,广泛应用于小儿咳嗽、食积、纳呆、眩晕、失眠及情志失调等痰湿相关病证,疗效显著。本文列举三则典型医案加以佐证,体现董幼祺教授“推理论病、推理论治”的学术思想,为二陈汤及类方在治疗小儿痰湿证中的应用提供宝贵临床经验。 展开更多
关键词 二陈汤 温胆汤 六君子汤 董幼祺 儿童
暂未订购
六君子汤联合西医治疗对非小细胞肺癌术后慢性咳嗽患者中医证候及肺功能的影响
11
作者 刘家良 郑凯 《临床合理用药》 2026年第6期4-8,共5页
目的观察六君子汤联合西医治疗对非小细胞肺癌(NSCLC)术后慢性咳嗽患者中医证候及肺功能的影响。方法选择2022年3月—2025年3月辽宁中医药大学附属医院收治的NSCLC术后慢性咳嗽患者92例,按随机数字表法分为观察组和对照组,各46例。对照... 目的观察六君子汤联合西医治疗对非小细胞肺癌(NSCLC)术后慢性咳嗽患者中医证候及肺功能的影响。方法选择2022年3月—2025年3月辽宁中医药大学附属医院收治的NSCLC术后慢性咳嗽患者92例,按随机数字表法分为观察组和对照组,各46例。对照组予以西医常规治疗,观察组在对照组基础上联合六君子汤治疗,2组均持续治疗4周。比较2组临床疗效,治疗前后中医证候积分、肺功能[第1秒用力呼气容积(FEV_(1))、用力肺活量(FVC)、FEV_(1)/FVC]、炎性因子[白介素-6(IL-6)、C反应蛋白(CRP)、肿瘤坏死因子-α(TNF-α)]及不良反应。结果观察组治疗总有效率(95.65%)高于对照组(82.61%)(χ^(2)=4.039,P=0.045)。治疗4周后,2组咳嗽反复发作、咳声低弱、痰多色白质稀积分低于治疗前,且观察组低于对照组(P<0.01);2组FEV_(1)、FVC、FEV_(1)/FVC高于治疗前,且观察组高于对照组(P<0.05或P<0.01);2组IL-6、CRP、TNF-α水平低于治疗前,且观察组低于对照组(P<0.01)。观察组与对照组不良反应总发生率比较差异无统计学意义(17.39%vs.13.04%,χ^(2)=0.337,P=0.562)。结论六君子汤联合西医治疗NSCLC术后慢性咳嗽患者疗效确切,可有效减轻其临床症状及炎性反应,促进肺功能改善,且不会明显增加不良反应。 展开更多
关键词 慢性咳嗽 非小细胞肺癌 术后 六君子汤 西医治疗 中医证候 肺功能 炎性因子 不良反应
原文传递
加味黄芪六君子汤联合针灸及穴位敷贴治疗肺脾气虚型咳嗽变异性哮喘临床研究
12
作者 郭婷婷 李倩倩 应一 《新中医》 2026年第7期8-14,共7页
目的:观察加味黄芪六君子汤联合针灸及穴位敷贴治疗肺脾气虚型咳嗽变异性哮喘(CVA)的临床疗效。方法:选取2024年8月—2025年6月仙居县人民医院收治的60例肺脾气虚型CVA患者,按随机数字表法分为对照组和观察组各30例。2组均给予常规对症... 目的:观察加味黄芪六君子汤联合针灸及穴位敷贴治疗肺脾气虚型咳嗽变异性哮喘(CVA)的临床疗效。方法:选取2024年8月—2025年6月仙居县人民医院收治的60例肺脾气虚型CVA患者,按随机数字表法分为对照组和观察组各30例。2组均给予常规对症治疗,在此基础上对照组予以布地奈德福莫特罗吸入粉雾剂治疗,观察组予以加味黄芪六君子汤联合针灸及穴位敷贴治疗。2组均以10天为1个疗程,治疗1个疗程后休息3天,治疗3个疗程。评价2组临床疗效,比较2组治疗前后中医证候积分、咳嗽症状积分、肺功能[呼气流量峰值(PEF)平均昼夜变异率、第1秒用力呼气容积占预计值百分比(FEV_(1)%pred)、FEV_(1)/用力肺活量(FVC)]、FEV_(1)改善率、嗜酸性粒细胞数(EOS)、咳嗽频率、免疫应答指标[辅助性T细胞(Th)1/Th2、干扰素-γ(IFN-γ)、白细胞介素-4(IL-4)]。结果:观察组总有效率为90.00%(27/30),对照组为76.67%(23/30),2组总有效率比较,差异无统计学意义(P>0.05)。治疗后,2组中医证候积分、咳嗽症状积分较治疗前降低(P<0.05),且观察组中医证候积分、咳嗽症状积分低于对照组(P<0.05)。治疗后,2组FEV_(1)%pred、FEV_(1)/FVC较治疗前升高,PEF平均昼夜变异率较治疗前降低(P<0.05);且观察组FEV_(1)%pred、FEV_(1)/FVC高于对照组,PEF平均昼夜变异率低于对照组(P<0.05)。治疗后,2组EOS水平较治疗前降低(P<0.05);且观察组EOS水平低于对照组(P<0.05)。治疗后,2组咳嗽频率较治疗前降低(P<0.05),且观察组咳嗽频率低于对照组(P<0.05)。治疗后,2组Th1/Th2、IFN-γ较治疗前升高,IL-4较治疗前降低(P<0.05);且观察组Th1/Th2、IFN-γ高于对照组,IL-4低于对照组(P<0.05)。2组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:在“培土生金”理论指导下,采用加味黄芪六君子汤联合针灸及穴位敷贴能降低肺脾气虚型CVA患者的咳嗽频率,有助于控制咳嗽症状,提高肺功能,促进CVA患者康复。 展开更多
关键词 咳嗽变异性哮喘 肺脾气虚型 培土生金 黄芪六君子汤 针灸 穴位敷贴 肺功能 免疫功能
原文传递
香砂六君子汤加减对慢性萎缩性胃炎癌前病变的干预及对胃黏膜相关因子水平的影响
13
作者 陈马兰 郭莲 +1 位作者 黄雄涛 章雄英 《中华中医药学刊》 北大核心 2026年第3期159-163,I0050,共6页
目的探讨香砂六君子汤加减对慢性萎缩性胃炎癌前病变的干预研究及对胃黏膜相关因子水平的影响。方法选取2021年5月—2024年4月浙江中医药大学附属金华中医院就诊中的100例脾胃虚弱型慢性萎缩性胃炎患者,用随机数字表法分为对照组和联合... 目的探讨香砂六君子汤加减对慢性萎缩性胃炎癌前病变的干预研究及对胃黏膜相关因子水平的影响。方法选取2021年5月—2024年4月浙江中医药大学附属金华中医院就诊中的100例脾胃虚弱型慢性萎缩性胃炎患者,用随机数字表法分为对照组和联合组,各50例。两组患者入院后嘱清淡饮食,忌辛辣刺激食物,并注意休息。对照组患者予叶酸联合胃复春片治疗,联合组在上述基础上予香砂六君子汤加减治疗,以4周为1个疗程,连用3个疗程。治疗结束后,比较两组患者中医证候积分、临床总有效率、胃镜病理积分及治疗过程中的不良反应,及对胃黏膜相关因子一氧化氮(Nitric Oxide,NO)、P选择素(Recombinant P-Selectin,SELP)、白细胞内皮细胞黏附分子-1(leukocyte endothelial cell adhesion molecule-1,LECAM-1)、内皮素-1(Endothelin-1,ET-1)变化情况。结果(1)中医症状积分:治疗后两组各个症状积分均低于治疗前(P<0.05),且联合组对于改善胃痛、嗳气、纳呆、大便稀溏、气短懒言、疲倦乏力6项中医症状积分优于对照组(P<0.05)。两组对于胃脘胀满改善差异无统计学意义(P>0.05)。(2)临床疗效:联合组临床总有效率为94.00%,与对照组(72.00%)比较显著升高,差异有统计学意义(P<0.05)。(3)胃镜病理积分:治疗后两组患者的胃镜病理积分较治疗前均有降低(P<0.05),且联合组各项胃镜病理积分与对照组比较均降低(P<0.05)。(4)治疗后,两组患者NO、SELP、LECAM-1、ET-1较治疗前降低(P<0.05);且联合组较对照组降低更为显著,差异有统计学意义(P<0.05)。(5)不良反应:联合组治疗期间不良反应发生率为8.00%,低于对照组(14.00%),但差异无统计学意义(P>0.05)。结论香砂六君子汤加减对于脾胃虚弱型慢性萎缩性胃炎患者有一定治疗效果,可提高总有效率,改善患者病理状况,抑制NO、SELP、LECAM-1、ET-1的分泌,调节患者胃黏膜炎性微环境,起到保护胃黏膜的作用。 展开更多
关键词 香砂六君子汤 慢性萎缩性胃炎 癌前病变 胃黏膜相关因子
原文传递
香砂六君子汤联合四联疗法治疗儿童幽门螺杆菌感染性消化性溃疡疗效分析
14
作者 王维 曹红 《中国烧伤创疡杂志》 2026年第1期60-64,共5页
目的分析儿童幽门螺杆菌感染性消化性溃疡应用香砂六君子汤联合四联疗法治疗的临床疗效。方法选取2021年6月至2024年6月南阳市第二人民医院收治的90例幽门螺杆菌感染性消化性溃疡患儿作为研究对象,依据随机数表法分为研究组(45例)与对照... 目的分析儿童幽门螺杆菌感染性消化性溃疡应用香砂六君子汤联合四联疗法治疗的临床疗效。方法选取2021年6月至2024年6月南阳市第二人民医院收治的90例幽门螺杆菌感染性消化性溃疡患儿作为研究对象,依据随机数表法分为研究组(45例)与对照组(45例),研究组患儿采用香砂六君子汤联合四联疗法治疗,对照组患儿单纯采用四联疗法治疗,对比观察两组患儿免疫指标、炎症介质与胃肠激素水平以及幽门螺杆菌根除率。结果治疗第7、14天,研究组患儿血管细胞黏附分子-1(VCAM-1)、肿瘤坏死因子-α(TNF-α)、环氧合酶-2(COX-2)以及胃泌素-17(GAS-17)、胃动素(MTL)水平均低于对照组(治疗第7天:t=2.360、2.497、2.372、2.165、8.176,P=0.021、P=0.014、P=0.020、P=0.033、P<0.001;治疗第14天:t=2.063、2.462、2.208、2.053、6.202,P=0.042、P=0.016、P=0.030、P=0.043、P<0.001),生长抑素(SST)水平均高于对照组(t=2.133、2.055,P=0.036、0.043);治疗结束后1个月,研究组患儿幽门螺杆菌根除率与对照组无明显差异(χ^(2)=3.462,P=0.063)。结论与单纯四联疗法治疗相比,香砂六君子汤联合四联疗法更能明显改善幽门螺杆菌感染性消化性溃疡患儿机体免疫功能,降低炎症反应程度,稳定胃肠功能状态,提高幽门螺杆菌清除效果。 展开更多
关键词 四联疗法 香砂六君子汤 儿童 消化性溃疡 幽门螺杆菌
暂未订购
六君子汤加减治疗透析患者蛋白质能量消耗临床观察
15
作者 邱斌辉 宋宇 +1 位作者 李艳存 刘伟敬 《山西中医》 2026年第4期26-28,共3页
目的:观察六君子汤加减对维持性透析患者蛋白质能量消耗的临床疗效。方法:选符合纳入标准的透析患者52例,随机分为两组各26例。对照组予西医常规治疗,治疗组在对照组基础上予六君子汤加减。治疗12周后比较两组患者体重、体质量指数、白... 目的:观察六君子汤加减对维持性透析患者蛋白质能量消耗的临床疗效。方法:选符合纳入标准的透析患者52例,随机分为两组各26例。对照组予西医常规治疗,治疗组在对照组基础上予六君子汤加减。治疗12周后比较两组患者体重、体质量指数、白蛋白、前白蛋白、C反应蛋白水平及营养不良-炎症状态评分、中医证候积分。结果:治疗组总有效率为83.33%,对照组为12.00%,两组比较差异有统计学意义(P﹤0.05)。治疗后,两组患者体重、体质量指数、白蛋白、前白蛋白水平均升高(P﹤0.05),C反应蛋白、营养不良-炎症状态评分、中医证候积分均下降(P﹤0.05),且治疗组上述指标水平均优于对照组(P﹤0.05)。结论:用六君子汤加减治疗维持性透析患者合并蛋白质能量消耗,可改善患者胃肠道症状、纠正其营养不良,疗效较好。 展开更多
关键词 维持性血液透析 蛋白质能量消耗 六君子汤加减 中医药疗法
暂未订购
基于文献分析及网络药理学探究柴芍六君子汤治疗卒中后抑郁共病失眠的作用机制
16
作者 尹婉君 何志传 谭静 《四川中医》 2026年第3期81-94,共14页
目的本研究基于文献分析与网络药理学系统探究柴芍六君子汤(CSLJZT)拆分的疏肝理气组、健脾益气组、和胃化痰组及全方组治疗卒中后抑郁(PSD)共病失眠的作用机制。方法依据中医组方理论将CSLJZT进行分组,基于TCMSP筛选CSLJZT的活性成分... 目的本研究基于文献分析与网络药理学系统探究柴芍六君子汤(CSLJZT)拆分的疏肝理气组、健脾益气组、和胃化痰组及全方组治疗卒中后抑郁(PSD)共病失眠的作用机制。方法依据中医组方理论将CSLJZT进行分组,基于TCMSP筛选CSLJZT的活性成分与潜在靶点,通过GeneCards、OMIM、Disgenet、TTD数据库进行靶点预测,以识别PSD共病失眠相关基因,通过Venn图分析得到中药复方各组与疾病的交集靶点。利用Cytoscape构建“药物-活性成分-靶点”网络,并分析蛋白质-蛋白质相互作用(PPI)网络,以识别各组核心靶点。进行GO和KEGG通路富集分析,探索相关生物过程和信号通路。结果根据组方理论将CSLJZT分为疏肝理气组(柴胡、白芍)、健脾益气组(人参、茯苓、白术、甘草)、和胃化痰组(半夏、陈皮)及CSLJZT全方,与共病的交集靶点分别为138个、161个、91个和173个。关键活性成分包括槲皮素、山奈酚、β-谷甾醇、7-甲氧基-2-甲基异黄酮、川陈皮素、异鼠李素、鹰嘴豆芽素A、芒柄花素等;核心靶点如TP53、AKT1、JUN、STAT3、IL6、TNF、MAPK1/3、HSP90AA1、ESR1、BCL2等。富集分析表明,疏肝理气组、健脾益气组及全方主要富集于脂质与动脉粥样硬化、AGE-RAGE等通路,共同调控神经炎症、细胞凋亡与氧化应激;而和胃化痰组则富集于神经活性配体-受体相互作用通路,提示其通过调节神经递质稳态发挥作用。结论柴芍六君子汤通过多组分、多靶点、多通路整合机制,治疗PSD共病失眠,其中疏肝理气组、健脾益气组主要通过神经炎症、细胞凋亡、氧化应激等信号通路,发挥抗炎、调控细胞凋亡、抗氧化及促进神经和血管再生的作用,而和胃化痰组则侧重调节神经递质发挥调节睡眠、抗抑郁、抗炎的作用,从而印证了其“调肝-治脾-和胃”的中医治疗原则,并揭示了其现代科学内涵。 展开更多
关键词 柴芍六君子汤 卒中后抑郁 失眠 文献探究 网络药理学 作用机制
原文传递
中药烫熨联合香砂六君子汤在重症监护室机械通气腹胀患者中的应用效果
17
作者 李磊 黄博宇 +2 位作者 黄美云 赵义 陈潇 《中国当代医药》 2026年第5期74-78,共5页
目的探讨中药烫熨联合香砂六君子汤在重症监护室(ICU)机械通气腹胀患者中的应用效果。方法选取2022年7月至2023年12月萍乡市中医院ICU收治的80例机械通气腹胀患者作为研究对象,按照随机数字表法分为对照组和观察组,每组40例。对照组予... 目的探讨中药烫熨联合香砂六君子汤在重症监护室(ICU)机械通气腹胀患者中的应用效果。方法选取2022年7月至2023年12月萍乡市中医院ICU收治的80例机械通气腹胀患者作为研究对象,按照随机数字表法分为对照组和观察组,每组40例。对照组予以中药烫熨,观察组在对照组的基础给予香砂六君子汤治疗。比较两组治疗前后中医证候积分、临床指标、腹内压(IAP)、动脉血气、临床疗效及不良反应。结果治疗后,观察组中医证候积分低于对照组,差异有统计学意义(P<0.05);观察组机械通气时间、ICU住院时间、肠鸣音恢复时间、首次排气时间均短于对照组,腹围缩小值大于对照组,差异有统计学意义(P<0.05);治疗后,观察组IAP水平低于对照组,pH、动脉血氧分压(PaO_(2))水平均高于对照组,动脉血二氧化碳分压(PaCO_(2))低于对照组,差异有统计学意义(P<0.05);观察组治疗总有效率高于对照组,差异有统计学意义(P<0.05);两组患者不良反应发生率比较,差异无统计学意义(P>0.05)。结论中药烫熨联合香砂六君子汤可降低ICU机械通气腹胀患者IAP,促进胃肠功能恢复,有效缓解腹胀,改善动脉血气,临床疗效好,且安全性较高,值得在ICU腹胀管理中推广。 展开更多
关键词 中药烫熨 香砂六君子汤 重症监护室 机械通气 腹胀 临床疗效
暂未订购
加味六君子汤联合PD-1免疫抑制剂治疗肺癌患者的临床疗效
18
作者 崔红学 傅玲 +2 位作者 郑祎 董峰言 张明月 《中国医药指南》 2026年第3期144-146,共3页
目的对加味六君子汤联合PD-1免疫抑制剂在肺癌患者治疗中的临床疗效予以探讨。方法选取本院收治的90例非小细胞肺癌患者,均为2024年7月至2025年1月收治,以随机数字表法分为对照组与观察组,分别接受单纯PD-1免疫抑制剂治疗、PD-1免疫抑... 目的对加味六君子汤联合PD-1免疫抑制剂在肺癌患者治疗中的临床疗效予以探讨。方法选取本院收治的90例非小细胞肺癌患者,均为2024年7月至2025年1月收治,以随机数字表法分为对照组与观察组,分别接受单纯PD-1免疫抑制剂治疗、PD-1免疫抑制剂联合加味六君子汤治疗,每组45例。对比两组临床疗效。结果观察组临床治疗总有效率高于对照组,免疫功能优于对照组,中医证候积分低于对照组(P<0.05);两组不良反应发生率差异无统计学意义(P>0.05)。结论加味六君子汤联合PD-1免疫抑制剂应用于肺癌患者的治疗中,能够有效改善患者免疫功能、降低患者中医证候积分,且不会增加患者不良反应发生率,临床治疗效果好、安全性高,值得在临床中应用。 展开更多
关键词 肺癌 加味六君子汤 PD-1免疫抑制剂 中医证候积分
暂未订购
六君子汤加减治疗慢阻肺痰湿蕴肺证的临床效果及对炎症因子的影响
19
作者 王梅 崔蕾 李想 《延边大学医学学报》 2026年第3期119-121,共3页
目的:探讨六君子汤加减治疗慢性阻塞性肺疾病(简称为慢阻肺)痰湿蕴肺证的临床疗效及对炎症因子的影响。方法:选取2022年5月至2025年5月北京王府中西医结合医院收治的76例慢阻肺痰湿蕴肺证患者,随机分为两组,各38例。两组均接受常规西医... 目的:探讨六君子汤加减治疗慢性阻塞性肺疾病(简称为慢阻肺)痰湿蕴肺证的临床疗效及对炎症因子的影响。方法:选取2022年5月至2025年5月北京王府中西医结合医院收治的76例慢阻肺痰湿蕴肺证患者,随机分为两组,各38例。两组均接受常规西医治疗,结合组加用六君子汤加减治疗。观察两组治疗前后肺功能指标、炎症因子及临床疗效。结果:治疗后,结合组肺功能指标高于对照组,各项炎症因子水平低于对照组,总有效率高于对照组(P<0.05)。结论:在常规西医治疗的基础上,使用六君子汤加减治疗慢阻肺痰湿蕴肺证能更好地发挥抗炎作用、改善肺功能、缓解临床症状,值得临床推广。 展开更多
关键词 慢性阻塞性肺疾病 痰湿蕴肺证 六君子汤 炎症因子
原文传递
脾肾气虚型慢性肾小球肾炎应用六君子汤合肾气丸改良方治疗的临床观察
20
作者 陈彦明 袁雪 陈婵婵 《黑龙江医学》 2026年第6期666-668,共3页
目的:探究脾肾气虚型慢性肾小球肾炎患者运用六君子汤合肾气丸改良方开展治疗的实际效果。方法:选取2022年3月—2025年3月于南阳市第一人民医院接受诊治的101例慢性肾小球肾炎患者作为研究对象。运用分层区组随机化方法将患者分为基础... 目的:探究脾肾气虚型慢性肾小球肾炎患者运用六君子汤合肾气丸改良方开展治疗的实际效果。方法:选取2022年3月—2025年3月于南阳市第一人民医院接受诊治的101例慢性肾小球肾炎患者作为研究对象。运用分层区组随机化方法将患者分为基础治疗组与综合治疗组,基础治疗组患者50例,综合治疗组患者51例。基础治疗组实施慢性肾小球肾炎的常规西医治疗手段,综合治疗组额外加用六君子汤合肾气丸改良方。在治疗过程中,密切观察并记录两组患者的临床疗效、中医证候积分以及炎性因子水平。结果:联合治疗组总有效率比常规治疗组高,联合治疗组中医证候积分、血清超敏C反应蛋白(hs-CRP)、白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)水平及血尿素氮(BUN)、血肌酐(Scr)、24小时尿蛋白定量(24 h-Upro)水平均优于常规治疗组,差异均有统计学意义(P<0.05)。结论:六君子汤合肾气丸改良方治脾肾气虚型慢性肾小球肾炎疗效显著,可改善脾肾功能、抑制炎症,安全性佳。 展开更多
关键词 脾肾气虚型 慢性肾小球肾炎 六君子汤合肾气丸
暂未订购
上一页 1 2 44 下一页 到第
使用帮助 返回顶部